Fluoxetine (Prozac) During Breastfeeding
Fluoxetine is generally NOT recommended as a first-line antidepressant during breastfeeding due to higher infant exposure and documented adverse effects, though it may be continued if the mother was already taking it during pregnancy. 1
FDA Label Position
The FDA drug label explicitly states: "Because Prozac is excreted in human milk, nursing while on Prozac is not recommended." 1 This recommendation is based on documented cases where:
- One infant developed crying, sleep disturbance, vomiting, and watery stools while breastfeeding, with measurable plasma drug levels (340 ng/mL fluoxetine and 208 ng/mL norfluoxetine) 1
- Fluoxetine concentrations in breast milk reached 70.4 ng/mL (compared to maternal plasma of 295.0 ng/mL) 1
Why Fluoxetine Is Problematic
Fluoxetine has the longest half-life of all SSRIs, and both the parent drug and its active metabolite (norfluoxetine) accumulate in measurable quantities in nursing infants 2. Research demonstrates:
- 30% of infants had detectable fluoxetine in serum (up to 84 ng/mL) 3
- 85% had detectable norfluoxetine (up to 265 ng/mL) 3
- One study found reduced weight gain in breastfed infants (average deficit of 392 grams between 2 weeks and 6 months) compared to infants whose mothers didn't take the medication 4
- Peak breast milk concentrations occur 8 hours after maternal dosing 3
Preferred Alternatives
Sertraline and paroxetine are the preferred SSRIs during breastfeeding because they produce very low or undetectable infant plasma concentrations 5, 2. The AAP guideline emphasizes that most maternal medications are compatible with breastfeeding, and appropriate substitutes can usually be found 6.
When Fluoxetine May Be Acceptable
If a mother was successfully treated with fluoxetine during pregnancy, continuing it during breastfeeding may be reasonable rather than switching medications 2. This is because:
- The infant has already been exposed in utero
- Switching antidepressants risks maternal relapse
- Individual risk-benefit assessment should be performed 2
Lower doses (≤20 mg/day) are significantly less likely to produce detectable infant concentrations compared to higher doses 3.
Monitoring Requirements
If fluoxetine is used during breastfeeding, monitor the infant for:
- Excessive crying or irritability
- Sleep disturbances
- Feeding difficulties or vomiting
- Poor weight gain (plot growth curves carefully)
- Unusual sedation or behavioral changes
One infant with measurable plasma fluoxetine showed a substantial decline in platelet serotonin to 40% of baseline, though this normalized when drug levels became undetectable 7.
Clinical Decision Algorithm
- Is the mother already on fluoxetine from pregnancy? → May continue with close infant monitoring
- Starting new antidepressant treatment? → Choose sertraline or paroxetine instead 5, 2
- Mother insists on fluoxetine? → Use lowest effective dose (≤20 mg/day), avoid exclusive breastfeeding if possible, monitor infant weight gain closely 3
- Any infant adverse effects observed? → Consider switching to sertraline/paroxetine or discontinuing breastfeeding
Key Caveat
The AAP guideline notes that LactMed (National Library of Medicine database) is the most comprehensive source for medication safety during breastfeeding 6. Always consult this resource for the most current data, as individual patient factors may modify recommendations.